A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781.
(Q42544672)
scientific article published on February 10, 1998
scientific article published on February 10, 1998
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||||||||||||||||||
| (P304) |
255-260
|
||||||||||||||||||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||||||||||||||||||
| (P433) |
3
|
||||||||||||||||||||||||||||||||
| (P478) |
14
|
||||||||||||||||||||||||||||||||
| (P577) |
Sunday, February 1, 1998
|
||||||||||||||||||||||||||||||||
| (P1433) |
(Q4651880)
|
||||||||||||||||||||||||||||||||
| (P1476) |
"A novel mutation (F227L) arises in the reverse transcriptase of human immunodeficiency virus type 1 on dose-escalating treatment of HIV type 1-infected cell cultures with the nonnucleoside reverse transcriptase inhibitor thiocarboxanilide UC-781." (language: en)
|
||||||||||||||||||||||||||||||||
| (P2093) |
Balzarini J
Pelemans H
Esnouf R
De Clercq E
|
other details
| description | scientific article published on February 10, 1998 |
External Links
| (P356) |
10.1089/AID.1998.14.255
|
| (P698) |
9491916
|